Chemical architecture of fluorinated nucleoside dimers containing 1,2,3-triazole linker of potential use in molecular biology and medicine
2019/35/D/NZ7/03637
Keywords
Descriptors
- ST4_003: Struktura i architektura molekularna
- ST4_009: Chemia biologiczna
- NZ7_014: Farmacja, farmakoterapia, farmakologia
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Instytut Chemii Bioorganicznej PAN
Voivodeship: wielkopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 3
Call
SONATA 15 – announced on 2019-09-16
- Amount awarded
- 1 086 720 PLN
- Project start date
- 2020-06-25
- Project end date
- 2025-09-24
- Project duration
- 63 months (the same as in the proposal)
- Project status
- Project completed
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
Triazole-Modified Nucleic Acids for the Application in Bioorganic and Medicinal Chemistry
- Authors:
- Dagmara Baraniak, Jerzy Boryski
- Academic press:
- Biomedicines (year: 2021, volume: 9, pages: 628), Publisher: MDPI
- Status:
- Published
- DOI:
- 10.3390/biomedicines9060628 – link to the publication